News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Metzger Michael A
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/08/2023 |
4
| Metzger Michael A (CEO) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 5,959 shares
@ $27.6384, valued at
$164.7k
Exercised 5,959 options to buy
@ $6.38, valued at
$38k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/07/2022 |
4
| Metzger Michael A (CEO) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 16,231 shares
@ $25.2916, valued at
$410.5k
Exercised 16,231 options to buy
@ $8.77, valued at
$142.3k
|
|
| 10/04/2022 |
4
| Metzger Michael A (CEO) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 29,606 shares
@ $25.0205, valued at
$740.8k
Sold 2,883 shares
@ $25.011, valued at
$72.1k
Sold 1,280 shares
@ $25.0206, valued at
$32k
Exercised 29,606 options to buy
@ $8.77, valued at
$259.6k
Exercised 2,883 options to buy
@ $8.77, valued at
$25.3k
Exercised 1,280 options to buy
@ $8.77, valued at
$11.2k
|
|
| 07/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/27/2021 |
4
| Metzger Michael A (President and COO) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 44,704 shares
@ $19.1333, valued at
$855.3k
Sold 16,296 shares
@ $19.1964, valued at
$312.8k
Exercised 44,704 options to buy
@ $7.2, valued at
$321.9k
Exercised 16,296 options to buy
@ $7.2, valued at
$117.3k
|
|
| 09/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2020 |
4
| Metzger Michael A (President and COO) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 15,000 shares
@ $22.9675, valued at
$344.5k
Exercised 15,000 options to buy
@ $7.2, valued at
$108k
|
|
| 11/06/2020 |
4
| Metzger Michael A (President and COO) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 100,000 shares
@ $20.3141, valued at
$2M
Exercised 100,000 options to buy
@ $7.2, valued at
$720k
|
|
| 03/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2019 |
4
| Metzger Michael A (President and COO) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Granted 200,000 options to buy
@ $9.15, valued at
$1.8M
|
|
| 05/20/2019 |
4
| Metzger Michael A (Director) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 120,000 options to buy
@ $0.8411, valued at
$100.9k
|
|
| 02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2018 |
4
| Metzger Michael A (Director) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 60,000 options to buy
@ $4.61, valued at
$276.6k
|
|
| 03/05/2018 |
4
| Metzger Michael A (President and COO) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Granted 125,000 options to buy
@ $9.4, valued at
$1.2M
|
|
| 01/22/2018 |
4
| Metzger Michael A (Director) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Exercised 20,121 restricted stock units
@ $0 |
|
| 02/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/24/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 02/20/2015 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 12/05/2014 |
4
| Metzger Michael A (President & CEO) has filed a Form 4 on Regado Biosciences Inc|
Txns:
| Granted 837,531 options to buy
@ $0.85, valued at
$711.9k
|
|
|
|
|